Skip to main content

Language: English / GĂ idhlig


Chamber and committees

Question ref. S6W-07156
Asked by: Fulton MacGregor, Coatbridge and Chryston, Scottish National Party
Date lodged: 10 March 2022


To ask the Scottish Government whether it will provide an update on current considerations regarding advice to NHS boards on the routine use of sapropterin in NHS Scotland.

Current status: Answered by Humza Yousaf on 28 March 2022


The first generic version of sapropterin has recently received a Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). Healthcare Improvement Scotland are working to provide updated advice to Boards to enable routine prescribing of Sapropterin. We expect this to be in place in April. In the meantime, doctors can request access to medicines that are not generally available on the NHS on an individual case-by-case basis through local health board medicine governance processes.